ST. PAUL — Two Twin Cities-area companies will grow and distribute marijuana for Minnesota’s medical cannabis program, state officials announced Monday, filling in just one of many blanks as the state gears up to provide the newly legalized treatment.

The Minnesota Department of Health chose Minnesota Medical Solutions, or MinnMed, and LeafLine Labs from a field of 12 applicants, ending a weekslong selection process. Both companies are led by local physicians but will collaborate with organizations involved with medical marijuana in other states. LeafLine Labs has strong connections with the Bachman floral family — several members are co-owners.

Now, a seven-month sprint begins for the providers to get their growing facilities up and running, nail down distribution systems and register patients in time to deliver medication to Minnesotans starting July 1.

“There certainly is plenty of work ahead before we see medical cannabis products available in Minnesota,” Health Commissioner Ed Ehlinger said.

But many questions remain.